Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

C. Hyde, B. Wake, S. Bryan, P. M. Barton, A. Fry-Smith, C. Davenport, F. Song

Research output: Contribution to journal › Article

13 Citations (Scopus)

Original language	English
Pages (from-to)	1-89
Number of pages	89
Journal	Health Technology Assessment
Volume	6
Issue number	2
DOIs	https://doi.org/10.3310/hta6020
Publication status	Published - 2002

Access to Document

@article{094263bceaff4854aa5ff4e832fc5106,

title = "Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment",

author = "C. Hyde and B. Wake and S. Bryan and Barton, {P. M.} and A. Fry-Smith and C. Davenport and F. Song",

year = "2002",

doi = "10.3310/hta6020",

language = "English",

volume = "6",

pages = "1--89",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "National Co-ordinating Centre for HTA",

number = "2",

}

TY - JOUR

T1 - Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

AU - Hyde, C.

AU - Wake, B.

AU - Bryan, S.

AU - Barton, P. M.

AU - Fry-Smith, A.

AU - Davenport, C.

AU - Song, F.

PY - 2002

Y1 - 2002

U2 - 10.3310/hta6020

DO - 10.3310/hta6020

M3 - Article

SN - 2046-4924

VL - 6

SP - 1

EP - 89

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 2

ER -